Lv61
2470 积分 2024-09-29 加入
Real-world Characteristics and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer Receiving Chemotherapy Versus Androgen Receptor-targeted Therapy After Failure of First-line Androgen Receptor-targeted Therapy in the Community Setting
3天前
已完结
Glycol chitosan stabilized nanomedicine of lapatinib and doxorubicin for the management of metastatic breast tumor
3天前
已完结
A comprehensive literature review and meta‐analysis of the prevalence of pan‐cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies
8天前
已完结
Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy
15天前
已完结
Scale for the assessment and rating of ataxia
29天前
已完结
MA18.11 A Phase Ib/II Study of Senaparib in Combination with Low-dose Temozolomide: Updated Results in Relapsed ES-SCLC Patients
1个月前
已完结
Targeting Supramolecular Active Complexes of Na v 1.7/Na v 1.8 to Relieve Chronic Neuropathic Pain
1个月前
已完结
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
1个月前
已完结
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study
1个月前
已完结
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial
2个月前
已完结
皖公网安备34019202002308
